We're excited to announce the combination of Berkeley Lights and IsoPlexis, bringing together the Beacon and IsoSpark platforms to form the premier functional cell biology company. Visit Site
The new Opto™ Plasma B Discovery 4.0 workflow on the Beacon® system advances from B cells to lead molecules in just 1 week. With this powerful workflow, you can:
Get a quick breakdown of this workflow from antibody expert, Anupam Singhal, PhD in his video tour.
In this GEN webinar, hear Genovac’s Patricia Odermatt and Iwona Budnicki present case studies and discuss how they utilized the Opto Plasma B Discovery workflow to rapidly discover antibodies against challenging targets, like GPCRs.
In March 2020, scientists at Vanderbilt University found antibodies that neutralized SARS-CoV-2 in under three weeks, using our Opto™ Viral Neutralization Workflow. Two of those antibodies now comprise AstraZeneca’s promising antibody cocktail in Phase III Clinical Trials. Get a behind -the-scenes look at the workflow and hear from the Vanderbilt team about the process.